We are live on ! Find out more
PWP

Perfromance Wealth Partners Portfolio holdings

AUM $3.45B
1-Year Est. Return 29.14%
This Fund
S&P 500
This Quarter Est. Return
+14.2%
1 Year Est. Return
+29.14%
3 Year Est. Return
+97.78%
5 Year Est. Return
10 Year Est. Return
AUM
$2.71B
AUM Growth
+$331M
Cap. Flow
+$23.1M
Cap. Flow %
0.85%
Top 10 Hldgs %
86.11%
Holding
184
New
18
Increased
34
Reduced
58
Closed
20

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$26M
2
COST icon
Costco
COST
+$23M
3
ORCL icon
Oracle
ORCL
+$21.9M
4
NVDA icon
NVIDIA
NVDA
+$18.5M
5
GS icon
Goldman Sachs
GS
+$17.1M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$40M
2
VTV icon
Vanguard Value ETF
VTV
+$22.6M
3
BX icon
Blackstone
BX
+$13.9M
4
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$11.2M
5
MCD icon
McDonald's
MCD
+$9.92M

Sector Composition

Rank Sector Weight
1 Technology 46.89%
2 Consumer Discretionary 7.63%
3 Financials 7.22%
4 Communication Services 6.1%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LULU icon
176
lululemon athletica
LULU
$13.8B
-1,559
Closed -$609K
MCD icon
177
McDonald's
MCD
$198B
-35,199
Closed -$9.92M
OEF icon
178
iShares S&P 100 ETF
OEF
$19.8B
-6,457
Closed -$1.18M
PTLO icon
179
Portillo's
PTLO
$339M
-12,900
Closed -$183K
RMD icon
180
ResMed
RMD
$30.4B
-1,050
Closed -$208K
SNY icon
181
Sanofi
SNY
$109B
-4,119
Closed -$200K
UNP icon
182
Union Pacific
UNP
$179B
-855
Closed -$210K
WTFC icon
183
Wintrust Financial
WTFC
$10.8B
-9,000
Closed -$210K
RVNC
184
DELISTED
Revance Therapeutics, Inc.
RVNC
-16,500
Closed -$81.2K

Similar funds

Perfromance Wealth Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Perfromance Wealth Partners held 184 positions worth $2.71B, up 14% from $2.38B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Perfromance Wealth Partners's Q2 2024 filing shows 18 new, 34 increased, 58 reduced and 20 closed positions. Its largest new stake was Invesco NASDAQ 100 ETF: 5,946 shares worth $1.17M. The largest sale was Visa, an estimated $40M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Perfromance Wealth Partners's largest Q2 2024 buy was Invesco NASDAQ 100 ETF: 5,946 shares worth $1.17M.
  • Perfromance Wealth Partners added most to Eli Lilly in Q2 2024, an estimated $26M increase.
  • Perfromance Wealth Partners's biggest Q2 2024 reduction was Visa, cutting an estimated $40M.
  • Perfromance Wealth Partners fully exited McDonald's in Q2 2024, selling an estimated $9.92M.
  • Perfromance Wealth Partners's ten largest holdings make up 86% of its $2.71B portfolio in Q2 2024.
  • Perfromance Wealth Partners opened 18 new positions and closed 20 in Q2 2024.
  • Perfromance Wealth Partners's portfolio value rose 14% quarter-over-quarter to $2.71B.

Based on Perfromance Wealth Partners's 13F filing for Q2 2024, filed 22 Jul 2024.